Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)

Clinical trial NCT03888131 · COMPLETED

Trial details

NCT number: NCT03888131
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2018-07-30
Primary completion: 2022-05-06
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.